In the past, chemotherapy is something many have been all about because we are told it saves lives, right? Well, what if I told you that several studies from the past few years said it was doing much more harm than good?

Chemotherapy and radiation are something pushed on everyone who is diagnosed with various forms of cancer. When it comes to trying natural alternatives, doctors are very against it. We are told that these treatments are hard on the body but that they are the only thing that works but that is just not true. They are so much more damaging than anyone is ever fully aware of when face to face with them. These methods while most will not want to accept it can kill.

Researchers back in 2016 from several organizations recently came together to work on a study that has made a serious dent in the mainstream medicinal narrative that pushes Chemotherapy and so forth. This study was published in The Lancet and is titled ’30-day morality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.’

This study was a turning point for all we know now. For this study, the researchers looked at the death rates across several hospitals in the UK and found that the mortality rates were quite shocking in regards to Chemotherapy treatment. While this might not be something people think about often, they should.

Their findings were as follows:

Our findings show that several factors affect the risk of early mortality of breast and lung cancer patients in England and that some groups are at a substantially increased risk of 30-day mortality. The identification of hospitals with significantly higher 30-day mortality rates should promote review of clinical decision making in these hospitals. Furthermore, our results highlight the importance of collecting routine data beyond clinical trials to better understand the factors placing patients at higher risk of 30-day mortality, and ultimately improve clinical decision making. Our insights into the factors affecting risk of 30-day mortality will help treating clinicians and their patients predict the balance of harms and benefits associated with SACT.

Basically, depending on which hospital you’re at, you might be either getting too much or not enough and suffering because of it, more so than you would be otherwise. Across England, it was found that rates are much higher in some hospitals when it comes to those who died within a month. These being treatment-related deaths.